Umban, Venerando S.

HRN: 26-27-38  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/05/2026
01/18/2026
IV
4.5
Q8
Non Healing Wound
Waiting Final Action 
01/05/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/05/2026
01/18/2026
IV
600
Q6
Non Healing Wound
Waiting Final Action 
01/05/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/05/2026
01/11/2026
IV
2.25
Q8
NON HEALING WOUND
Waiting Final Action 
01/07/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/07/2026
01/14/2026
IV
2.25
Q6H
Non Healing Wound
Waiting Final Action 
01/20/2026
CEFTAZIDIME 1GM (VIAL)
01/20/2026
01/27/2026
IV
2g
Q12H
Infected Wound
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: